Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia-Reference-Cited by-同舟云学术

Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Published:2017-11-22 Issue:11 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Jung Jae Hung¹²³,Kim Jiye⁴,MacDonald Roderick⁵,Reddy Balaji⁶,Kim Myung Ha⁷,Dahm Philipp²³

Affiliation:

1. Yonsei University Wonju College of Medicine; Department of Urology; 20 Ilsan-ro Wonju Gangwon Korea, South 26426

2. University of Minnesota; Department of Urology; Minneapolis Minnesota USA

3. Minneapolis VA Health Care System; Urology Section; Minneapolis Minnesota USA

4. Yonsei University Wonju College of Medicine; Department of Plastic Surgery; Wonju Korea, South

5. Minneapolis VA Medical Center; General Internal Medicine (111-0); One Veterans Drive Minneapolis Minnesota USA 55417

6. Massachusetts General Hospital; Department of Urology; 55 Fruit Street Boston USA MA 02114

7. Yonsei University Wonju College of Medicine; Yonsei Wonju Medical Library; Wonju Korea, South

Publisher

Wiley

Subject

Pharmacology (medical)

Reference143 articles.

1. Efficacy of silodosin as compared with tamsulosin and placebo for the treatment of the signs and symptoms of benign prostatic hyperplasia. a multicentre, randomised, double-blind, controlled trial;Chapple;European Urology Supplements,2010

2. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe;Chapple;European Urology,2011

3. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe;Chapple;Urologia,2012

4. EUCTR2005-005665-11-GB Evaluation of the efficacy and safety of silodosin vs. Tamsulosin and placebo in the treatment of the signs and symptoms of benign prostatic hyperplasia. Multicentre, randomised, double-blind, controlled trial with an optional long-term open-label extension phase apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-005665-11-GB

5. NCT00359905 Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH https://clinicaltrials.gov/ct2/show/NCT00359905?term=NCT00359905&rank=1

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electronic medical records-based retrospective, longitudinal, observational study to understand the patient management of benign prostatic hyperplasia with alpha-blockers monotherapy in Indian population;Urology Annals;2023

2. Persistence to Medications for Benign Prostatic Hyperplasia/Benign Prostatic Obstruction-Associated Lower Urinary Tract Symptoms in the ASL TO4 Regione Piemonte (Italy);Healthcare;2022-12-17

3. Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: a systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing;BMC Geriatrics;2022-09-28

4. Prostatic arterial embolisation for men with benign prostatic hyperplasia: a Cochrane review;BJU International;2022-07-13

5. Medical Treatment of Benign Prostatic Hyperplasia;Urologic Clinics of North America;2022-05